ClinicalTrials.gg
CompletedNCT02982382Updated Feb 25, 2019

Effects of Manipulative Therapy and Pain Education in Individuals With CLBP

An interventional study of Manipulative Therapy and Pain Education in Low Back Pain, sponsored by Santa Catarina Federal University. Completed at 1 site in Brazil. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-02-25.

Sponsored by Santa Catarina Federal University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 125 studies in Low Back Pain with a site in Brazil — 10 open to participants now, 12 under way, none of them phase 3. Low Back Pain · Brazil.

Enrollment
31st of 122
128 · median 66
Started
2016
with 9 others
No phase
101 of 125
9 open now
Registered
64th of 125
by date

Among the 125 studies in Low Back Pain with a site in Brazil, this one is the 31st largest by enrollment of the 122 interventional ones that give a count, is one of 10 that started in 2016, is one of 101 with no phase, and was the 64th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

10 of the 125 studies in Low Back Pain with a site in Brazil are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 125 studies in Low Back Pain with a site in Brazil, or all of them as a file.
02

Study summary

The burden of low back pain more than doubled in the last 20 years, probably caused by biopsychosocial factors. Some noninvasive treatments have been applied in individuals with chronic nonspecific low back pain as spinal manipulation and pain education. However, it is not already clear the neurophysiological effects of these treatments.The purpose of this research is to verify the effects of the technique of spinal manipulation and pain education in individuals with chronic low back pain

Read the detailed description

The outcomes will be subjective pain (measured by Numeric Pain Rating Scale), pressure pain threshold (measured by Algometer), disability (measured by Roland-Morris Disability Questionnaire), fear and avoidance beliefs (measured by Fear Avoidance Beliefs Questionnaire), risk of poor prognosis (measured by STarT Back Screening Tool), quality of life (measured by Short Form-12v2) and blood biomarkers (measured by ELISA). The data will be collected by a blinded assessor.

Individuals eligibility is going to be assessed by blinded assessor to determine if they are or not eligible for this research. Then, they will be informed about the objectives of this study and asked to sign the consent form. Afterward, the sociodemographic data will be recorded. The data related to the research outcomes will be collected by the blinded assessor at baseline assessment, after six weeks and three months.

Random Allocation Before the treatment begins, one of the researchers not involved in the recruiting and assessment will allocate the individuals in one of the groups. Block randomization will be used; it is going to generate by randomization.com, this site will create a list with the randomization sequence, which will be only seen by the physical therapists that will treat the individuals.

Statistical Methods

Sample size calculation The sample size calculation was calculated with the A-priori test with the following specifications: Statistical test ANCOVA, the effect size of 0.25, the statistical power of 80%, and an alpha level of 5%. As a result, the study requires a sample size of 64 per group or 128 individuals in total.

Analysis of effects of treatment Our research will use the intention-to-treat principles. The descriptive data and the scores of RMDQ, SBST, FABQ, SF-12v2 and NPRS as well as the pressure pain threshold means and the values of inflammatory biomarkers, before and after interventions, will be tabbed on Microsoft Excel 2010. To see the effect of treatment is going to be used statistical based on intention-to-treat principles, statistical analyses will be used to analyses data of individuals socio-demographics and clinics characteristics, and they will be presented by mean and standard deviation. To compare the groups, Shapiro-Wilk test will be applied to test the normality distribution of data, depending on this distribution will be used ANOVA one-way for parametric data or Kruskal-Wallis test for non-parametric data. To compare groups on the pre-intervention period another ANOVA-one way or another Kruskal-Wallis will be applied.

Covariance analysis (ANCOVA) will be conducted to assess the effect of treatment on the following outcomes: Scores obtained on RMDQ, FABQ, SF-12v2, SBST and NPRS, pressure pain threshold and the blood biomarkers concentrations, utilizing the post-treatment means as dependent variables, the pre-treatment means as co-variables and the group as fixed factor.

To the relationships among the variables must be applied the Pearson correlation coefficient to parametric data and Spearman correlation coefficient to nonparametric data. To classify the relationships will be used the Munro's classification, where values between 0.26 and 0.49 will be low, values between 0.50 and 0.69 will be moderate, between 0.70 and 0.89 will be high values, and between 0.90 and 1.0 will be considered very high. For all of these analyses will be used the Statistical Package for the Social Sciences (IBM SPSS version 20.0, IBM Corp, Armonk, New York).

03

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • Low Back Pain
  • Musculoskeletal Manipulations
  • Neurophysiology
  • Education
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Chronic episodes of nonspecific LBP for at least six months
  • Pain on movement for at least one direction (flexion, extension, side bending or rotation of the trunk)
  • At least score 3 in NPRS.

Exclusion criteria

Exclusion Criteria:

    1. Previous history of lumbar myelopathy, rheumatic disease, tumors, peripheral or central neurological disorders
    1. Historical of trauma, fracture or surgery in lumbar region;
    1. Nerve root compression signs: important muscle weakness affecting lower limb, decrease or abolish of patellar and calcaneus reflex and decrease of dermatomes sensibility of lower limbs.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
128 participants (actual)

Study arms

  • Experimental
    Manipulative Treatment

    Subjects will receive Manipulative Therapy

    Other: Manipulative Therapy · Other: Pain Education

  • Sham comparator
    Pain Education

    Subjects will receive Pain Education and manual contact over lumbar region

    Other: Pain Education · Other: Sham

Interventions

  • OtherManipulative Therapy

    Subjects will receive techniques of High Velocity and Low Amplitude (HVLA) or grade V manipulation to the lumbar region (lumbar roll), and pain education based on the biopsychosocial approach.

    Also known as: Manual Therapy, Grade V Manipulation, Spinal Manipulation

  • OtherPain Education

    Individuals will receive pain education based in a biopsychosocial approach

    Also known as: Neuroscience Pain Education

  • OtherSham

    The individuals will receive a simulation of spinal manipulation (sham) involving manual contact over lumbar region totaling 5 minutes.

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Numeric Pain Rating Scale (NPRS)

    Time frame: 6 weeks after randomization

Secondary outcomes

  1. Pain Intensity

    Numeric Pain Rating Scale (NPRS)

    Time frame: Baseline, 6 weeks and 3 months

  2. Disabilty

    Rolland Morris Disability Questionnaire (RMDQ)

    Time frame: baseline, 6 weeks and 3 months

  3. Pressure Pain Threshold

    The pressure pain threshold will be assessed by algometer. It will be realized three times in each point (Five centimeters of the right and left side of the spinal process of L1, L3 and L5, and on the muscle belly of tibialis anterior).

    Time frame: Baseline, 6 weeks and 3 months

  4. Fear and Beliefs about pain

    Fear Avoidance Belief Questionnaire (FABQ)

    Time frame: Baseline, 6 weeks and 3 months

  5. Risk of poor prognosis

    STarT Back Screening Tool (SBST)

    Time frame: Baseline, 6 weeks and 3 months

  6. Quality of Life

    Short-Form Health Survey 12 version 2 (SF-12v2)

    Time frame: Baseline, 6 weeks and 3 months

  7. Serum Level of Cytokines

    Enzyme Linked Immunosorbent Assay (ELISA) to TNF-α, IL-1β, IL-4, IL-6, IL-8, IL-12, IL-10, IL-15, MIP-4, CCL18, MCP-3 / CCL7, MCP-2 / CCL8, IGP - 10 / CXCL10, Stromal Lymphopoietin Receptor (TSLR), Interferon Gamma and CRP.

    Time frame: Baseline, 6 weeks

07

Study locations

1 site
  • Santa Catarina Federal University
    Florianopolis, Santa Catarina 88040-900, Brazil
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2016, a primary completion of Dec 2018 and a completion of Dec 2018. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 29, 2016
First posted
Dec 5, 2016
Start
Dec 2016
Primary completionActual
Dec 2018
CompletionActual
Dec 2018
Last update
Feb 25, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02982382
Lead sponsor
Santa Catarina Federal University
Responsible party
Clecio Vier (Principal Investigator, Santa Catarina Federal University) — Principal investigator
First posted
Dec 5, 2016
Start date
Dec 2016
Primary completion
Dec 2018
Completion
Dec 2018
Last update
Feb 25, 2019

Study contacts

Clécio Vier, PhD Student
principal investigator · Santa Catarina Federal University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion